Applied Value Group

CatchProbe is a technology company that specializes in providing actionable web intelligence, threat intelligence, and digital crime analytics solutions through its innovative AI-Driven SaaS-based platform. This centralized intelligence platform, known as the Intelligency Suite, facilitates comprehensive intelligence gathering and analysis, enabling organizations to prevent potential threats and enhance their data through correlation across various sources. CatchProbe employs a range of methodologies, including verified threat intelligence from public and private sources, AI-based deception systems, and resources from the dark and deep web. Its suite of products includes tools such as the Intelligence and Crime Analytics Center, DarkMap, Threatway, and others, which assist analysts in conducting deep analyses and generating meaningful insights from collected data. By streamlining threat prevention and providing accurate analysis, CatchProbe aims to empower organizations to make informed decisions in the realm of cybersecurity and intelligence.

Cezy is an online retailer specializing in the production of healthy snacks. Their primary product is a bar made from figs, carrots, walnuts, honey, and molasses, with no added flavors or additives. They also offer vegan carrot cube bars with peanuts, oranges, and walnuts, providing customers with a range of natural, fiber-rich options.

Medrics specializes in developing integrated solutions that enhance patient experiences while improving hospital operations. Their offerings combine healthcare process knowledge with mobile and location technologies, all tailored to clients' specific needs.

CosmosID, Inc. is a bioinformatics company that specializes in microbial genomics, providing a platform for the rapid characterization of microorganisms and pathogens. Established in 2007 and based in Rockville, Maryland, CosmosID focuses on applications in infectious disease diagnostics, food safety inspections, pharmaceutical discovery, public health surveillance, and microbiome analysis. The company offers testing services for various pathogens, including SARS-CoV-2, and serves a diverse clientele that includes clinics, hospitals, healthcare professionals, the public health sector, industries, and research laboratories. By enabling effective identification and analysis of microorganisms, CosmosID aims to enhance treatment options and support public health initiatives.